Clinical Trial Update: Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bimatoprost 0.01% alone with travoprost 0.004% and timolol 0.5% in glaucoma or ocular hypertension. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Lumigan (bimatoprost)
• TRAVATAN Z (TRAVOPROST)
• Timolol (timolol)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2016-01-14